Winch Advisory Services’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$124K Hold
653
0.03% 129
2026
Q1
$110K Sell
653
-18
-3% -$3.08K 0.03% 129
2025
Q4
$113K Sell
671
-17
-2% -$2.76K 0.03% 124
2025
Q3
$99.3K Hold
688
0.02% 131
2025
Q2
$87K Sell
688
-29
-4% -$3.56K 0.02% 132
2025
Q1
$91.7K Buy
717
+1
+0.1% +$136 0.02% 122
2024
Q4
$94.7K Hold
716
0.02% 119
2024
Q3
$104K Buy
716
+1
+0.1% +$145 0.03% 112
2024
Q2
$98.1K Sell
715
-124
-15% -$16.6K 0.03% 112
2024
Q1
$115K Sell
839
-59
-7% -$8.06K 0.04% 106
2023
Q4
$122K Sell
898
-146
-14% -$17.8K 0.04% 101
2023
Q3
$128K Sell
1,044
-45
-4% -$5.72K 0.05% 91
2023
Q2
$138K Sell
1,089
-144
-12% -$18.7K 0.05% 89
2023
Q1
$159K Sell
1,233
-57
-4% -$7.46K 0.06% 83
2022
Q4
$169K Sell
1,290
-122
-9% -$15.8K 0.07% 80
2022
Q3
$165K Buy
1,412
+1
+0.1% +$124 0.07% 73
2022
Q2
$166K Sell
1,411
-104
-7% -$12.3K 0.07% 74
2022
Q1
$197K Hold
1,515
0.07% 76
2021
Q4
$231K Buy
1,515
+91
+6% +$14.1K 0.08% 75
2021
Q3
$230K Sell
1,424
-75
-5% -$12.6K 0.08% 69
2021
Q2
$245K Buy
1,499
+16
+1% +$2.46K 0.09% 66
2021
Q1
$223K Buy
1,483
+112
+8% +$17.8K 0.09% 62
2020
Q4
$208K Buy
1,371
+22
+2% +$3.14K 0.09% 60
2020
Q3
$183K Buy
1,349
+82
+6% +$11.1K 0.08% 58
2020
Q2
$173K Buy
1,267
+91
+8% +$11.6K 0.08% 56
2020
Q1
$127K Hold
1,176
0.06% 55
2019
Q4
$142K Sell
1,176
-969
-45% -$108K 0.07% 69
2019
Q3
$213K Sell
2,145
-163
-7% -$17.1K 0.11% 62
2019
Q2
$252K Sell
2,308
-173
-7% -$18.4K 0.13% 59
2019
Q1
$277K Buy
2,481
+257
+12% +$28.2K 0.15% 65
2018
Q4
$214K Sell
2,224
-40,378
-95% -$4.29M 0.12% 64
2018
Q3
$5.2M Buy
42,602
+584
+1% +$68.8K 2.61% 13
2018
Q2
$4.61M Sell
42,018
-2,187
-5% -$234K 2.49% 15
2018
Q1
$4.72M Buy
44,205
+1,279
+3% +$142K 2.76% 11
2017
Q4
$4.58M Buy
42,926
+809
+2% +$86.5K 2.76% 14
2017
Q3
$4.68M Buy
42,117
+1,845
+5% +$197K 3.04% 13
2017
Q2
$4.16M Sell
40,272
-873
-2% -$86K 2.62% 14
2017
Q1
$4.02M Buy
41,145
+240
+0.6% +$23K 2.55% 11
2016
Q4
$3.62M Buy
40,905
+40,860
+90,800% +$3.72M 2.49% 13
2016
Q3
$4K Sell
45
-558
-93% -$53.1K ﹤0.01% 206
2016
Q2
$52K Buy
603
+579
+2,413% +$52K 0.06% 77
2016
Q1
$2K Hold
24
﹤0.01% 200
2015
Q4
$3K Buy
24
+3
+14% +$326 ﹤0.01% 196
2015
Q3
$2K Sell
21
-37,833
-100% -$4.54M ﹤0.01% 196
2015
Q2
$4.66M Buy
37,854
+25,593
+209% +$3.06M 2.54% 8
2015
Q1
$1.4M Sell
12,261
-45,567
-79% -$5.03M 0.82% 34
2014
Q4
$5.85M Buy
57,828
+48,816
+542% +$4.74M 3.18% 9
2014
Q3
$822K Buy
+9,012
New +$791K 0.53% 40

Other funds holding IBB

Winch Advisory Services's IBB Position: Q2 2026 in Review

Winch Advisory Services held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 653 shares worth $124K. The position accounts for 0.03% of the portfolio, ranked #129.

Winch Advisory Services first reported a position in IBB in Q3 2014 and has held it in 48 quarters since. The position peaked at $5.85M in Q4 2014. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Winch Advisory Services held 653 shares of iShares Biotechnology ETF worth $124K as of Q2 2026.
  • Winch Advisory Services left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up 0.03% of Winch Advisory Services's portfolio in Q2 2026, its #129 holding.
  • Winch Advisory Services first reported a position in iShares Biotechnology ETF in Q3 2014 and has held it in 48 quarters since.
  • Winch Advisory Services's iShares Biotechnology ETF position peaked at $5.85M in Q4 2014.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Winch Advisory Services's 13F filing for Q2 2026, filed 6 Aug 2026.